HeartSciences (HSCS) Income towards Parent Company (2021 - 2026)

HeartSciences (HSCS) has reported Income towards Parent Company for 6 consecutive years, with -$2.8 million the latest figure, recorded in Q2 2026.

• Quarterly Income towards Parent Company fell 31.57% year-over-year to -$2.8 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$22.5 million (up 55.8% YoY) and the FY2026 annual result came in at -$25.8 million, down 10.19% from the prior year.
• Income towards Parent Company retreated to -$2.8 million in Q2 2026 per HSCS's latest filing, from -$2.4 million in the prior quarter.
• Over the last five years, Income towards Parent Company for HSCS reached as high as -$1.2 million in Q1 2022 and fell as low as -$17.3 million in Q3 2025.
• A 5-year average of -$9.3 million and a median of -$12.4 million in 2023 frame the typical range for Income towards Parent Company.
• Annual changes were most pronounced in 2022 — Income towards Parent Company tumbled 1476.03% — and 2025, when it soared 85.34%.
• Year by year, Income towards Parent Company stood at -$12.5 million in 2022, then dropped by 11.23% to -$14.0 million in 2023, then retreated by 15.02% to -$16.0 million in 2024, then surged by 85.34% to -$2.4 million in 2025, then slipped by 17.5% to -$2.8 million in 2026.
• According to Business Quant data, Income towards Parent Company over the past three periods registered -$2.8 million, -$2.4 million, and -$17.3 million for Q2 2026, Q4 2025, and Q3 2025 respectively.